Markets:

Overview

News

Currencies

International

Treasuries

TransMedics Group, Inc. - Common Stock (NQ:TMDX)

146.00 +5.79 (+4.13%)

Streaming Delayed Price Updated: 4:00 PM EST, Nov 25, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about TransMedics Group, Inc. - Common Stock

< Previous 1 2

...

10 11 12 13 14 15 16 17 Next >

Earnings Scheduled For February 23, 2022 ↗

February 23, 2022

Companies Reporting Before The Bell • Sapiens Intl Corp (NASDAQ:SPNS) is likely to report earnings for its fourth quarter. • Plymouth Industrial REIT (NYSE:PLYM)...

Via Benzinga

The Daily Biotech Pulse: Merck Reports Positive Keytruda Readout, Moderna Slips Despite Q2 Beat, Bayer To Buy Vividion For Up To $2B, GlycoMimetics Gets New CEO ↗

August 05, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 4) Absci, CORP (NASDAQ: ABSI) (...

Via Benzinga

Why Is It Moving? Looking At TransMedics Group's Price Action Today ↗

April 07, 2021

TransMedics Group's Stock Price And Volume Action TransMedics Group's (NASDAQ:

Via Benzinga

The Daily Biotech Pulse: Valneva Inks COVID-19 Vaccine Supply Contract In Europe, I-Mab Spikes On China Deal, DermTech Sinks On Guidance ↗

November 10, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus MorphoSys COO To Leave To Pursue Other Opportunities MorphoSys AG (NASDAQ:...

Via Benzinga

TransMedics Reports Positive Data From OCS DCD Heart Trial ↗

November 04, 2021

TransMedics Group Inc (NASDAQ: TMDX) has announced topline results from its OCS donors after circulatory death (DCD) Heart Trial. Related: TransMedics' OCS Heart...

Via Benzinga

TransMedics' OCS Heart System Scores FDA Approval ↗

September 07, 2021

TransMedics Group Inc (NASDAQ: TMDX) has received FDA premarket approval (PMA) for its OCS Heart system. Related content: Benzinga's Full FDA...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

September 07, 2021

Gainers Pliant Therapeutics (NASDAQ:PLRX) shares rose 25.62% to $24.27 during Tuesday's pre-market session. The market value of their outstanding shares is at $872.2...

Via Benzinga

Looking into TransMedics Group's Return on Capital Employed ↗

August 30, 2021

Pulled from Benzinga Pro data TransMedics Group (NASDAQ:TMDX) reported Q2 sales of $8.17 million. Earnings fell to a loss of $9.87 million, resulting in a 51.65% decrease from...

Via Benzinga

Earnings Scheduled For August 5, 2021 ↗

August 05, 2021

Companies Reporting Before The Bell • OneSpaWorld Holdings (NASDAQ:OSW) is projected to report quarterly loss at $0.20 per share on revenue of $6.42 million. •...

Via Benzinga

The Week Ahead In Biotech (Aug. 1-7): Biopharma Earnings Pick Up Pace, Eton Awaits FDA Decision, Focus On Pending Clinical Readouts and IPOs ↗

August 01, 2021

Biotech stocks showed a lack of direction in the week ending July 30 amid earnings releases from big pharma companies. Most pharma majors reported strong quarterly results....

Via Benzinga

50 Biggest Movers From Friday ↗

July 19, 2021

Gainers Red Cat Holdings, Inc. (NASDAQ: RCAT) shares jumped 41.2% to settle at $7.10 on Friday. Blue Foundry Bancorp (NASDAQ: BLFY) gained 29% to close at $12.90 after the...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

July 15, 2021

Gainers Alterity Therapeutics (NASDAQ:ATHE) shares rose 13.66% to $1.58 during Thursday's pre-market session. The market value of their outstanding shares is at $63.3...

Via Benzinga

The Daily Biotech Pulse: Galapagos Sinks On Data, J&J Recalls Sunscreen Products, FibroGen Awaits AdCom Verdict, 3 IPOs ↗

July 15, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 14) Alexion Pharmaceuticals,...

Via Benzinga

Topics Product Recall

FDA Advisory Committee Gives Thumbs Up To TransMedics' OCS Liver System ↗

July 15, 2021

The Gastroenterology and Urology Devices Panel of the FDA's Medical Devices Advisory Committee has

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

July 12, 2021

Gainers Celldex Therapeutics (NASDAQ:CLDX) stock increased by 21.35% to $39.33 during Monday's regular session. Celldex Therapeutics's stock is trading at a volume...

Via Benzinga

The Daily Biotech Pulse: Lyra Gains On Positive Regulatory Outcome, FDA Nod For Pfizer's Prevnar Vaccine, Merck Inks COVID-19 Treatment Supply Deal With US ↗

June 09, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 8) Agios Pharmaceuticals, Inc...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

May 12, 2021

Gainers Celyad Oncology (NASDAQ:CYAD) sto...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

May 05, 2021

Gainers Chiasma (NASDAQ:CHMA) shares moved upwards by 41.9% to $4.03 during Wednesday's regular session. Chiasma's stock is trading at a volume of 75.5 million...

Via Benzinga

Recap: TransMedics Group Q1 Earnings ↗

May 04, 2021

Shares of TransMedics Group (NASDAQ:TMDX) were flat in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share were up 30.95% over the...

Via Benzinga

1 Feel-Good Healthcare Stock That Could Turn Your Tax Return Into Riches ↗

April 22, 2021

TransMedics is looking to disrupt an entire industry and help thousands of transplant patients in the U.S. in the process.

Via The Motley Fool

48 Biggest Movers From Yesterday ↗

April 22, 2021

Gainers Welbilt, Inc. (NYSE: WBT) shares surged 44.5% to close at $22.58 on Wednesday after The Middleby Corporation announced plans to acquire the company. Skillz Inc. (NYSE:...

Via Benzinga

Earnings Scheduled For May 4, 2021 ↗

May 04, 2021

Companies Reporting Before The Bell • Lancaster Colony (NASDAQ:LANC) is likely to report quarterly earnings at $1.24 per share on revenue of $340.02 million. •...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

April 21, 2021

Gainers Alterity Therapeutics (NASDAQ:ATHE) shares rose 17.59% to $1.47 during Wednesday's regular session. As of 12:31 EST, this security is trading at a volume of 55...

Via Benzinga

33 Stocks Moving In Wednesday's Mid-Day Session ↗

April 21, 2021

Gainers Welbilt, Inc. (NYSE: WBT) shares jumped 34.8% to $21.06 after The Middleby Corporation announced plans to acquire the company. Acme United Corporation (NYSE: ACU) gained...

Via Benzinga

Cramer Weighs In On Paysafe, Xilinx And More ↗

April 15, 2021

On CNBC's "Mad Money Lightning Round," Jim Cramer said Keysight Technologies Inc (NYSE: KEYS) has been just red hot and he really likes it. Amarin Corporation plc (...

Via Benzinga

TransMedics Stock Is Trading Higher After FDA Adcom Votes In Favor Of Its OCS Heart System ↗

April 07, 2021

The FDA Advisory Committee has voted in favor of TransMedics Group Inc (NASDAQ: TMDX) after reviewing clinical evidence from the OCS Heart EXPAND trial,...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

April 07, 2021

Gainers Titan Medical (NASDAQ:TMDI) shares rose 26.81% to $2.27 during Wednesday's pre-market session. The market value of their outstanding shares is at $248.6...

Via Benzinga

The Daily Biotech Pulse: FibroGen Fudges Safety Data, Novartis Strikes Cancer Drug Collaboration, Immutep Gains On Patent Award ↗

April 07, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 6) AngioDynamics, Inc. (NASDAQ...

Via Benzinga

Topics Intellectual Property

How Jonah Lupton Expects TransMedics Group Stock To React To FDA Decision ↗

April 06, 2021

Jonah Lupton of Lupton Capital was focused on TransMedics Group Inc (NASDAQ: TMDX) Tuesday. The Nasdaq halted trading in TransMedics stock while the FDA...

Via Benzinga

< Previous 1 2

...

10 11 12 13 14 15 16 17 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

TransMedics Group, Inc. - Common Stock (NQ:TMDX)

All News about TransMedics Group, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today